These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 9820038

  • 1. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II, Lopatkin NA, Khodyreva LA, Kondrat'eva EM.
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract] [Full Text] [Related]

  • 2. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
    Derevianko II, Khodyreva LA, Avdoshin VL, Andriukhin MI, Gabliia MIu.
    Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS, Talboys CA, Roberts AP.
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y, Ozaki M, Matsuda M, Honmura T, Nishimura I, Yamaguchi R, Adachi T, Okawa Y, Nishino T.
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [Abstract] [Full Text] [Related]

  • 5. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun 12; 34(872):58-60. PubMed ID: 1317502
    [No Abstract] [Full Text] [Related]

  • 6. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
    Savitskaia KI, Trapeznikova MF, Nekhorosheva AG, Solodilova OE, Nasonov VN, Dutov VV, Kalinin VN, Shanina AG, Rusanova EV.
    Klin Med (Mosk); 1994 Jun 12; 72(2):38-42. PubMed ID: 8015241
    [Abstract] [Full Text] [Related]

  • 7. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
    Spivey IM.
    Clin Pharm; 1993 Jun 12; 12(6):452-8. PubMed ID: 8403817
    [No Abstract] [Full Text] [Related]

  • 8. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
    Iakovlev SV.
    Urologiia; 2002 Jun 12; (1):11-4. PubMed ID: 11877963
    [Abstract] [Full Text] [Related]

  • 9. Quinolones for short-term treatment of uncomplicated urinary tract infection.
    Kadiri S, Ajayi SO, Toki RA.
    East Afr Med J; 1999 Oct 12; 76(10):587-9. PubMed ID: 10734512
    [Abstract] [Full Text] [Related]

  • 10. In vitro sensitivities of urinary tract pathogens to lomefloxacin and five other antimicrobial agents.
    Peddie BA.
    N Z Med J; 1989 Jun 14; 102(869):298. PubMed ID: 2733911
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
    Obana Y, Nishino T.
    Drugs Exp Clin Res; 1988 Jun 14; 14(5):327-31. PubMed ID: 3219995
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
    Scheen AJ.
    Rev Med Liege; 2000 Nov 14; 55(11):1015-7. PubMed ID: 11195704
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
    Krutikov MG, Alekseev AA, Bobrovnikov AE, Grishina IA, Elagina LV, Izotova GN, Iakovlev VP.
    Antibiot Khimioter; 1998 Nov 14; 43(10):27-31. PubMed ID: 9825107
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A clinical study of lomefloxacin on the patients with urinary tract infections--focused on lomefloxacin-induced photosensitivity reaction].
    Tozawa K, Washida H, Honma H, Kang K, Yamada Y.
    Hinyokika Kiyo; 1993 Sep 14; 39(9):801-5. PubMed ID: 8213373
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L, Schito AM, Schito GC, Marchese A.
    Int J Antimicrob Agents; 2007 Jun 14; 29(6):679-87. PubMed ID: 17363225
    [Abstract] [Full Text] [Related]

  • 20. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
    Jones RN.
    J Chemother; 1989 Jul 14; 1(4 Suppl):165-7. PubMed ID: 16312353
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.